Inactive Instrument

News Natco Pharma Ltd. NSE India S.E.

Equities

INE987B01018

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT
May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	May. 08	MT
Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	Apr. 09	MT
NATCO Pharma Limited Announces Board Appointments	Mar. 27	CI
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	Feb. 18	RE
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	Feb. 15	CI
Transcript : NATCO Pharma Limited, Q3 2024 Earnings Call, Feb 15, 2024	Feb. 15
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	Feb. 14	CI
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited	Jan. 16	CI
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	Dec. 07	MT
Transcript : NATCO Pharma Limited, Q2 2024 Earnings Call, Nov 15, 2023	Nov. 15
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	Nov. 14	MT
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	Nov. 14	CI
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	Nov. 02	MT
Transcript : NATCO Pharma Limited - Shareholder/Analyst Call	23-09-29
Redcliffe Hygiene Private Limited announced that it has received INR 248 million in funding from Rainmatter, Alkemi Growth Capital LLP, NATCO Pharma Limited	23-09-11	CI
Indian Equities End Higher for Sixth Straight Day, Buoyed by Banking, Public Sector Enterprises	23-09-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Natco Pharma Ltd. NSE India S.E.

Equities

INE987B01018

Summary

Filters